Nemifitide diTFA

Research use only, not for human use.

Nemifitide (diTFA) is is a synthetic pentapeptide antidepressant with a potential for rapid onset of action. Nemifitide (diTFA) is a peptide analog of melanocyte-inhibiting factor (MIF).

Nemifitide (diTFA) is is a synthetic pentapeptide antidepressant with a potential for rapid onset of action. Nemifitide (diTFA) is a peptide analog of melanocyte-inhibiting factor (MIF). (In Vitro):In-vitro studies indicate that both nemifitide and its active metabolite (M1) bind at micromolar concentrations to several receptors including the 5-HT2A, 5-HT2C, melanocortin MC4, MC5 and bombesin.(In Vivo):Nemifitide (0.3 mg/kg; IP; daily; for 14 days) significantly increases swimming in the FSL rats after just 5 days of treatment and has long-lasting effect. Nemifitide (0.0125-15.0 mg/kg) significantly increases swimming in the FSL rats at both low (0.025-0.3 mg/kg) and high (3.0-15.0 mg/kg) doses but not at intermediate (0.4-2.4 mg/kg) doses.

Nemifitide diTFA (INN 00835 diTFA) and its active metabolite (M1) bind at micromolar concentrations to several receptors including the 5-HT2A, 5-HT2C, melanocortin MC4, MC5 and bombesin.

Nemifitide diTFA (INN 00835 diTFA; 0.3 mg/kg; IP; daily; for 14 days) significantly increases swimming in the FSL rats after just 5 days of treatment and has long-lasting effect. Nemifitide diTFA (0.0125-15.0 mg/kg) significantly increases swimming in the FSL rats at both low (0.025-0.3 mg/kg) and high (3.0-15.0 mg/kg) doses but not at intermediate (0.4-2.4 mg/kg) doses. Animal Model:Male Flinders Sensitive Line (FSL) rat weighing 280-320 g Dosage:0.3 mg/kg Administration:IP; daily; for 14 days Result:Significantly increased swimming in the FSL rats after just 5 days of treatment and had long-lasting effect.

INN 00835 diTFA

Others

Other Targets

——

——

——

204992-09-6

922.8

C37H45F7N10O10

>98% (HPLC)

In Vitro:?H2O : 250 mg/mL (270.91 mM)

——

Sequence:{Fluoro-Phe}-{Hyp}-Arg-Gly-Trp-NH2

(-20℃)

With Ice Pack

≥ 2 years